Schedule 13G ownership disclosure

Aptevo Therapeutics Inc.

Security class unavailable · CUSIP: 03835L108

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,379,859
Percent of class
5.2600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001037389-20-000144
Form type
SC 13G/A
Filer
Aptevo Therapeutics Inc.
CIK
CIK 1671584
Filed
Feb 13, 2020
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub